sorafenib has been researched along with thymidine in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (thymidine) | Trials (thymidine) | Recent Studies (post-2010) (thymidine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 33,410 | 241 | 1,117 |
| Protein | Taxonomy | sorafenib (IC50) | thymidine (IC50) |
|---|---|---|---|
| Thymidine kinase | Macacine alphaherpesvirus 1 | 4.1 | |
| Thymidine kinase, cytosolic | Homo sapiens (human) | 0.614 | |
| Thymidine kinase | Human alphaherpesvirus 1 strain SC16 | 1 | |
| Sterol O-acyltransferase 1 | Cricetulus griseus (Chinese hamster) | 1.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Stefano, G; Fiume, L; Manerba, M; Vettraino, M | 1 |
1 other study(ies) available for sorafenib and thymidine
| Article | Year |
|---|---|
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Synergism; Glycolysis; Humans; L-Lactate Dehydrogenase; Liver Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Niacinamide; Oxamic Acid; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib; Thymidine | 2011 |